HOME >> MEDICINE >> NEWS
Newest version of 'the pill' confers same stroke risk as old pill

e with the three generations of oral contraceptives. Of the 203 stroke cases and 925 controls between the ages of 18 and 49, they found the risk of stroke in women taking any type of OC 2.3 times that of women not taking one.

The few women still using the first-generation pill were 1.7 times more likely to have a stroke than women not using any oral birth control. Women taking the third-generation pill had an increased stroke risk 2.2 times that of non-pill users. Those taking the second-generation pill formulations had 2.4 times the risk, says senior author Ale Algra, M.D., associate professor of clinical epidemiology at University Medical Center, Utrecht, Netherlands.

Risk factors for stroke smoking, hypertension, diabetes and high cholesterol appeared to add to the stroke risk in all pill users in the study.

Because there is virtually no difference in the risk of stroke in second- and third- generation pills, the balance of the decision whether to use second- or third- generation oral contraceptives should be determined by the risk of venous thrombosis, blood clots deep in the leg, Algra says.

Last year, Algra and his team linked third-generation OCs with an increased risk of developing blood clots in deep veins of the body (venous thrombosis). In a meta-analysis of previous studies of OCs, the group found a higher risk of venous thrombosis in third generation pills than of second-generation pills. Venous thrombosis usually resolves without complications, but the clots can travel to the lungs, causing a life-threatening pulmonary embolism.

Because of the risk of leg blood clots with third-generation OCs, Algra suggests women use second-generation OCs. Very few women take the first-generation version of the pill.

They seriously should consider using second-generation preparations if they did not use OCs before, or switching from third-generation pills to second-generation pills if they are current users, he stresses.


'"/>

Contact: Carole Bullock or Bridgette McNeill
210-582-7159
American Heart Association
7-Feb-2002


Page: 1 2 3

Related medicine news :

1. Newest Depression Medications Widely Prescribed For Children
2. Supporters of NIH policy see publishers gambit as possible diversion
3. Camera pill promising for diagnosis of small bowel disease
4. Virtual stomach reveals pills path
5. GSA confers 2004 Nathan Shock New Investigator Award to UTHSCs Marciniak
6. The Gerontological Society of America confers 2004 M. Powell Lawton Award to Penn States Zarit
7. GSA confers 2004 Joseph T. Freeman Award to St. Louis Universitys Morley
8. GSA confers 2004 Distinguished Mentorship in Gerontology Award to the Michigans Jackson
9. GSA confers 2004 Richard Kalish Innovative Publication Award to W. Ontarios Connidis and McMullin
10. The Gerontological Society of America confers 2003 Kalish Award to Utahs Pasupathi
11. The Gerontological Society of America confers 2003 Lawton Award to Columbia Universitys Gurland

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Newest version the pill confers same stroke risk old pill

(Date:7/31/2015)... ... ... ZH Healthcare announces a new cloud based service delivering Health IT as ... Service (HITaaS) is a Healthcare dedicated cloud based service that sits over infrastructure as ... all aspects of infrastructure, security, runtime, middleware, OS, virtualization, Servers, storage, contracts, and ...
(Date:7/31/2015)... ... ... therapy for knee osteoarthritis is an important part of knee pain treatment. ... doing what they want or need to do. The patient may have trouble getting in ... exercise regime may be limited by the pain in their knee. When a patient sees ...
(Date:7/31/2015)... ... , ... New Energy Works Timberframers invites the public to join their timber ... from 9am – 12pm. Timber frame raisings are special, celebrating both craft ... the culmination of months of effort, planning, fundraising, and dreaming takes shape. , ...
(Date:7/31/2015)... , ... July 31, 2015 , ... The Radiology ... Michael Burgess, MD, (R-Tex) presenting “What’s Next for Health Care: A View From Capitol ... and founder of the Congressional Health Caucus, Rep. Burgess has a special understanding of ...
(Date:7/31/2015)... ... ... “ Crack’em ” was featured on NewsWatch as part of its monthly ... Forstrom, a technology expert and special reporter for NewsWatch, conducted the review and shared ... can be a very messy experience, especially when cracking eggs. Cracking an egg is ...
Breaking Medicine News(10 mins):Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 4Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 2Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 3Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 2Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 3Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 2Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 3Health News:Make Less Mess while Cooking with Crack’em 2
(Date:7/30/2015)... , July 30, 2015 Eisai Inc. announced ... the United States , European Union and ... and MHLW, respectively) for eribulin, for the treatment of ... received prior chemotherapy for advanced or metastatic disease. ... from a pivotal global Phase 3 clinical trial (Study ...
(Date:7/30/2015)... 30, 2015  Medimetriks Pharmaceuticals, Inc. announced today ... III clinical study for Ozenoxacin, a novel bactericidal ... the exclusive U.S. rights to Ozenoxacin 1% cream.  ... 44 centers with an emphasis on U.S. patients, ... months and older with a clinical diagnosis of ...
(Date:7/30/2015)... FRANCISCO , July 30, 2015 ... market is expected to reach USD 23.01 million ... View Research, Inc. Growing base of geriatric population, increasing ... infections, and rising level of awareness among target customer ... rendering drivers over the forecast period. According to estimates ...
Breaking Medicine Technology:Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 2ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 4ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 5
Cached News: